Guardion Health Sciences is a drug manufacturers - specialty & generic business based in the US. Guardion Health Sciences shares (GHSI.US) are listed on the NASDAQ and all prices are listed in US dollars. Its last market close was $8.09 ā a decrease of 0.31% over the previous day. Guardion Health Sciences employs 9 staff and has a trailing 12-month revenue of around $12.2 million.
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Over the last 12 months, Guardion Health Sciences's shares have ranged in value from as little as $5.0102 up to $10.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Guardion Health Sciences's is 0.88. This would suggest that Guardion Health Sciences's shares are less volatile than average (for this exchange).
Historical closes compared with the last close of $8.085
| 1 week (2024-05-02) | 1.06% |
|---|---|
| 1 month (2024-04-09) | 2.34% |
| 3 months (2024-02-08) | -0.31% |
| 6 months (2023-11-09) | 34.53% |
| 1 year (2023-05-09) | 27.73% |
| 2 years (2022-05-04) | 4,391.67% |
| 3 years (2021-05-09) | 418.27% |
| 5 years (2019-05-09) | -14.72% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Guardion Health Sciences P/E ratio, PEG ratio and EBITDA
Guardion Health Sciences's current stock price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 67x. In other words, Guardion Health Sciences stocks trade at around 67x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
A deep dive into the highlights and limitations of Frec.
Explore the best bonuses for opening a new brokerage account.
Check out our picks of the best ETF brokers for beginners, options trading, micro-investing and more.
Access remote advice, planning and portfolio management from this established financial services company.
Get familiar with Canada’s largest stock exchange and find out how to buy TSX stocks.
Check out our picks of the best robo-advisors for new and experienced investors alike.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
M1 Finance strikes a balance between self-directed and automated investing. What you need to know before you sign up.
What you need to know about investing in the leading indicator for the overall US stock market.